“Patent think” continues to retrench and retrace after SCOTUS’ series of unanimous rulings that ended patents for discovery of laws of nature, and for most applications of math. A cogent summary of the rulings is provided in a July 21, 2015 blog post by John Conley at the Genomics Law Report.  Unlike some never

The litigation industry seldom lacks for people spinning an "issue," creating a faux "issue" or just plain spewing out talking points for some side without the burden of actual knowledge or adequate information.  A new example of spin and counter-spin arises as the Economist took a swing at patent law, patent trolls, NPES, etc. P

Myriad Genetics has lost again in its efforts to claim patent protection for reading the sequence of the so-called BRCA genes associated with breast cancer.  This time, a federal judge in its home state denied its request for a preliminary injunction against another company that will sequence BRCA genes for about half the price charged

Is litigation all bad? Apparently not, at least judging by the actions of corporate America. Thus, corporations continue to embrace revenue-generating litigation, and use of patent litigation as a strategic business tool. The latest example arises in federal court in Texas, where Apple, Microsoft, Blackberry, Ericcson and Sony are the wizards behind the curtain for